| 日本語 |
|
||
|
|
|
|
||
|
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
|
|
| Home » Feature Article » A-Cube Inc.（記事一覧） |
|
| Feature Article |
|
|
A-Cube Inc.'s Articles
|
|
||||||||||||||||||||||||||||||||||||||||||
 |
| About Us | Contact | Privacy Policy | Copyright© JAIC Asia Holding Pte. Ltd. 2010 |
A-Cube Inc. (A-Cube) was founded in June 2003 in San Francisco by Dr. Hisaaki Kawakatsu and Dr. Nobuyuki Ota. Both the Japanese medical researchers, based in the San Francisco Bay Area, had an idea to design monoclonal antibodies which can detect activated disease causing proteins by using a proprietary computer simulation system. 
